S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
Log in
NASDAQ:BLRX

BioLineRx News Headlines

$2.25
-0.01 (-0.44 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$2.17
Now: $2.25
$2.27
50-Day Range
$1.47
MA: $1.99
$2.83
52-Week Range
$1.06
Now: $2.25
$3.30
Volume572,265 shs
Average Volume1.62 million shs
Market Capitalization$47.56 million
P/E RatioN/A
Dividend YieldN/A
Beta2.07

Headlines

BioLineRx (NASDAQ BLRX) News Headlines Today

Source:
SourceHeadline
Oppenheimer Weighs in on BioLineRx Ltd.s FY2020 Earnings (NASDAQ:BLRX)Oppenheimer Weighs in on BioLineRx Ltd.'s FY2020 Earnings (NASDAQ:BLRX)
americanbankingnews.com - November 26 at 7:49 AM
BioLineRx (NASDAQ:BLRX) Issues  Earnings ResultsBioLineRx (NASDAQ:BLRX) Issues Earnings Results
americanbankingnews.com - November 24 at 10:02 AM
Form 6-K BioLineRx Ltd. For: Nov 23 - StreetInsider.comForm 6-K BioLineRx Ltd. For: Nov 23 - StreetInsider.com
streetinsider.com - November 23 at 6:24 PM
BioLineRx Ltd. to Host Earnings Call - Yahoo FinanceBioLineRx Ltd. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - November 23 at 6:24 PM
BioLineRx down 12% despite Q3 earnings beatBioLineRx down 12% despite Q3 earnings beat
seekingalpha.com - November 23 at 1:23 PM
BioLineRxs (BLRX) CEO Phil Serlin on Q3 2020 Results - Earnings Call TranscriptBioLineRx's (BLRX) CEO Phil Serlin on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 23 at 1:23 PM
BioLineRx (NASDAQ:BLRX) Shares Gap Down to $2.64BioLineRx (NASDAQ:BLRX) Shares Gap Down to $2.64
americanbankingnews.com - November 23 at 12:03 PM
BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateBioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 23 at 8:21 AM
BioLineRx (NASDAQ:BLRX) Stock Price Up 5.5%BioLineRx (NASDAQ:BLRX) Stock Price Up 5.5%
americanbankingnews.com - November 19 at 7:46 PM
BioLineRx (BLRX) Begins Phase 1b Clinical Trial in Patients with ARDS Secondary to COVID-19 & Other Respiratory Viral Infections - StreetInsider.comBioLineRx (BLRX) Begins Phase 1b Clinical Trial in Patients with ARDS Secondary to COVID-19 & Other Respiratory Viral Infections - StreetInsider.com
streetinsider.com - November 19 at 6:14 PM
BioLineRx (BLRX) Set to Announce Quarterly Earnings on MondayBioLineRx (BLRX) Set to Announce Quarterly Earnings on Monday
americanbankingnews.com - November 19 at 1:15 PM
BioLineRx launches early-stage study with lead asset in COVID-19 related respiratory distressBioLineRx launches early-stage study with lead asset in COVID-19 related respiratory distress
seekingalpha.com - November 18 at 12:09 PM
BioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory Distress Syndrome (ARDS) Secondary to COVID-19 and Other Respiratory Viral Infections - PRNewswireBioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory Distress Syndrome (ARDS) Secondary to COVID-19 and Other Respiratory Viral Infections - PRNewswire
prnewswire.com - November 18 at 7:08 AM
BioLineRx to Report Third Quarter 2020 Results on November 23, 2020BioLineRx to Report Third Quarter 2020 Results on November 23, 2020
finance.yahoo.com - November 18 at 7:08 AM
BioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory Distress Syndrome (ARDS) Secondary to COVID-19 and Other Respiratory Viral InfectionsBioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory Distress Syndrome (ARDS) Secondary to COVID-19 and Other Respiratory Viral Infections
finance.yahoo.com - November 18 at 7:08 AM
BioLineRx (NASDAQ:BLRX) Stock Price Down 5.1%BioLineRx (NASDAQ:BLRX) Stock Price Down 5.1%
americanbankingnews.com - November 16 at 10:36 PM
BioLineRx Ltd. (NASDAQ:BLRX) Expected to Announce Earnings of -$0.36 Per ShareBioLineRx Ltd. (NASDAQ:BLRX) Expected to Announce Earnings of -$0.36 Per Share
americanbankingnews.com - November 16 at 11:49 AM
Zoetis (ZTS) Librela Gets Marketing Authorization in Europe - NasdaqZoetis (ZTS) Librela Gets Marketing Authorization in Europe - Nasdaq
nasdaq.com - November 13 at 12:30 PM
Zoetis (ZTS) Librela Gets Marketing Authorization in EuropeZoetis (ZTS) Librela Gets Marketing Authorization in Europe
finance.yahoo.com - November 13 at 12:30 PM
ChemoCentryx (CCXI) Reports Wider-Than-Expected Q3 LossChemoCentryx (CCXI) Reports Wider-Than-Expected Q3 Loss
finance.yahoo.com - November 10 at 1:30 PM
Aerie (AERI) Q3 Loss Narrower Than Expected, Sales Rise Y/Y - NasdaqAerie (AERI) Q3 Loss Narrower Than Expected, Sales Rise Y/Y - Nasdaq
nasdaq.com - November 6 at 8:17 PM
BioLineRx (NASDAQ:BLRX)  Shares Down 8.1% BioLineRx (NASDAQ:BLRX) Shares Down 8.1%
americanbankingnews.com - November 6 at 7:21 PM
BioLineRx (NASDAQ:BLRX) Trading Up 5.6%BioLineRx (NASDAQ:BLRX) Trading Up 5.6%
americanbankingnews.com - November 5 at 9:15 PM
Perrigo (PRGO) Q3 Earnings Beat, Revenues Miss, Stock UpPerrigo (PRGO) Q3 Earnings Beat, Revenues Miss, Stock Up
finance.yahoo.com - November 5 at 12:59 PM
Oppenheimer Weighs in on BIOLINERX LTD/Ss Q3 2020 Earnings (NASDAQ:BLRX)Oppenheimer Weighs in on BIOLINERX LTD/S's Q3 2020 Earnings (NASDAQ:BLRX)
americanbankingnews.com - November 4 at 6:09 AM
BioLineRx Pops 34% On ‘Positive’ Results From Cancer Stem Cell TrialBioLineRx Pops 34% On ‘Positive’ Results From Cancer Stem Cell Trial
finance.yahoo.com - November 1 at 1:08 PM
BioLineRx launches mid-stage combo study in first-line pancreatic cancerBioLineRx launches mid-stage combo study in first-line pancreatic cancer
seekingalpha.com - October 30 at 6:41 PM
BioLine stock soars on heavy volume after compelling results of cancer treatment trialBioLine stock soars on heavy volume after 'compelling' results of cancer treatment trial
msn.com - October 30 at 1:41 PM
Why BioLineRxs Stock Is Trading Higher TodayWhy BioLineRx's Stock Is Trading Higher Today
benzinga.com - October 30 at 1:41 PM
BioLineRx Announces Positive Results from Interim Analysis of GENESIS Phase 3 Trial of Motixafortide (BL-8040) in Stem Cell MobilizationBioLineRx Announces Positive Results from Interim Analysis of GENESIS Phase 3 Trial of Motixafortide (BL-8040) in Stem Cell Mobilization
finance.yahoo.com - October 30 at 8:40 AM
BioLineRx Announces Initiation of Phase 2 Clinical Trial in First-Line Metastatic Pancreatic CancerBioLineRx Announces Initiation of Phase 2 Clinical Trial in First-Line Metastatic Pancreatic Cancer
finance.yahoo.com - October 29 at 9:08 AM
Radius Completes Enrollment in Phase III Osteoporosis StudyRadius Completes Enrollment in Phase III Osteoporosis Study
finance.yahoo.com - September 9 at 12:21 PM
JNJ Acquires MNTA, FDA Strikes Down BMRNs Gene Therapy, BLRXs GENESIS On Track, TPTX On WatchJNJ Acquires MNTA, FDA Strikes Down BMRN's Gene Therapy, BLRX's GENESIS On Track, TPTX On Watch
nasdaq.com - August 20 at 3:51 AM
BLRX.OQ - BioLineRX Ltd. Profile | ReutersBLRX.OQ - BioLineRX Ltd. Profile | Reuters
reuters.com - August 19 at 12:49 PM
BioLineRx Achieves Enrollment Target in Phase 3 GENESIS Trial for Planned Interim AnalysisBioLineRx Achieves Enrollment Target in Phase 3 GENESIS Trial for Planned Interim Analysis
finance.yahoo.com - August 19 at 7:42 AM
BioLineRx Ltd. (BLRX)BioLineRx Ltd. (BLRX)
finance.yahoo.com - August 16 at 9:55 AM
Catalysts (CPRX) Q2 Earnings & Revenues Beat EstimatesCatalyst's (CPRX) Q2 Earnings & Revenues Beat Estimates
finance.yahoo.com - August 11 at 3:20 PM
BioLine RX Ltd (BLRX) CEO Philip Serlin on Q2 2020 Results - Earnings Call TranscriptBioLine RX Ltd (BLRX) CEO Philip Serlin on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 3:52 AM
BioLineRx Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateBioLineRx Reports Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 6 at 12:44 PM
BioLineRx to Report Second Quarter 2020 Results on August 6, 2020BioLineRx to Report Second Quarter 2020 Results on August 6, 2020
finance.yahoo.com - July 31 at 10:39 AM
BioLineRx (BLRX) to Report Q2 Earnings: Whats in the Cards?BioLineRx (BLRX) to Report Q2 Earnings: What's in the Cards?
www.nasdaq.com - July 24 at 6:06 PM
BioLineRx (BLRX) to Report Q2 Earnings: What's in the Cards?BioLineRx (BLRX) to Report Q2 Earnings: What's in the Cards?
finance.yahoo.com - July 24 at 6:06 PM
Aclaris (ACRS) Surges: Stock Moves 5.4% HigherAclaris (ACRS) Surges: Stock Moves 5.4% Higher
finance.yahoo.com - July 8 at 1:01 PM
Zogenix (ZGNX) in Focus: Stock Moves 7.6% HigherZogenix (ZGNX) in Focus: Stock Moves 7.6% Higher
finance.yahoo.com - July 2 at 9:55 AM
Corcept Begins Enrollment in Phase III Pancreatic Cancer StudyCorcept Begins Enrollment in Phase III Pancreatic Cancer Study
www.nasdaq.com - July 1 at 1:22 PM
CytoDyn Signs MOU With NIH of Mexico for Coronavirus StudyCytoDyn Signs MOU With NIH of Mexico for Coronavirus Study
finance.yahoo.com - June 30 at 1:52 PM
Is Bioline RX Ltd (BLRX) Going to Burn These Hedge Funds?Is Bioline RX Ltd (BLRX) Going to Burn These Hedge Funds?
finance.yahoo.com - June 4 at 7:57 PM
BioLineRx Announces $4.39 Million Registered Direct OfferingBioLineRx Announces $4.39 Million Registered Direct Offering
finance.yahoo.com - June 1 at 8:31 AM
BioLineRx Announces Publication of Data from Ongoing COMBAT/KEYNOTE-202 Clinical Trial in Nature MedicineBioLineRx Announces Publication of Data from Ongoing COMBAT/KEYNOTE-202 Clinical Trial in Nature Medicine
finance.yahoo.com - May 27 at 8:43 AM
61 Stocks Moving In Tuesdays Mid-Day Session61 Stocks Moving In Tuesday's Mid-Day Session
www.msn.com - May 26 at 5:53 PM
This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.